RUBRA MEDICAMENTS LTD. - Board Meeting Intimation for Notice Of Board Meeting

Download	< Back
01 Aug 2022
RUBRA MEDICAMENTS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2022 ,inter alia, to consider and approve 1. Standalone Unaudited Financial Results along with limited review report of the Company for the quarter ended June 30, 2022. The Company shall intimate to the exchange the unaudited Financial Results upon the conclusion of the Board Meeting as required by SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. 2. Reappointment of Ms. Sneha Thakur (DIN: 07805202) as an Independent Director for a further period of 5 years from July 7, 2022 till July 6, 2027 subject to approval of members in forthcoming Annual General Meeting 3. To fix the dates of Book Closure for Annual General Meeting. 4. To decide the time, venue and date of Annual General Meeting.
View all announcements for RUBRA MEDICAMENTS LTD.	Source: BSE India

Stocks	Mutual Funds		Investment tracking
A-Z Gainers - Daily \| Weekly \| Monthly Losers - Daily \| Weekly \| Monthly Group-wise listing IPO \| Top IPOs Recent IPOs \| IPO News Similar Price band Most traded - By volumes Top 100 - By market capitalisation Latest Company Results Management Speaks Market News	Top 25 schemes High-risk, High-returns Medium-risk, Medium-returns Low-risk, Low-returns Gilt Funds Funds of Funds Special Funds Liquid Funds Dynamic Asset Allocation NFOs MF Selector	Equity - ELSS Equity - Index Funds Equity - Sector Funds Equity - Balance Fund Equity - Diversified Fund MF News Budget 2024	My Portfolio My Watch List If You Had Invested... Global Indicators Forex Converter Market Indices Sectoral Indices World Indices Market Astrology Advertise with us